Login
Toggle navigation
Videos
Categories
Trending
TrioTech Unveils Cutting-Edge Innovations at Press Conference | Siew Wai Yong, CEO AT Trio-Tech International
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Trio-Tech International's CEO is Siew Yong
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
IPH Limited (ASX:IPH) CEO and CFO Review FY19 Results with Morgans Network | Dr Andrew Blattman - CEO and Managing Director of IPH Ltd
00:10:00
Mag Silver's Presentation Overview: Financial Health, Project Progress, and Exploration Potential
00:10:00
Andrea Frazzini of AQR Capital Management Explores the Practical Application of Academic Research in Generating Investment Returns: Insights from the Yale School of Management
00:10:00
Sustainability Spotlight: Joao Bento on CTT Portugal Post | João Bento - CEO of CTT Correios de Portugal, S.A.
00:10:00
Pool Powerhouse: Hayward Holdings CEO Kevin Holleran Discusses Growth and Innovation | Kevin Holleran - CEO of Hayward Holdings Inc
00:10:00
Interview with Founding Partners of Antares Vision: Insights from Emidio Zorzella and Massimo Bonardi | Emidio Zorzella - CEO of Antares Vision S.p.A.
00:10:00
Structural Developments in the Nickel Industry: Insights and Implications
00:00:00
Anupam B. Jena, MD, PhD Joseph P. Newhouse Professor of Health Care Policy, Department of Health Care Policy, Harvard Medical School / Random Acts of Medicine
00:00:00
Bassam Sonbol, M.D. Hematologist / Oncologist, Mayo Clinic
00:10:00
Ross Beaty on Entrepreneurship in Mining: From Geology to Building Global Companies
00:10:00
Patrick Buchanan on the Decline of Western Civilization and Immigration Impact
00:10:00
We help our customers and clients plan and achieve their most important financial goals by delivering innovative products and services through intuitive digital experiences | Abigail Johnson,Chairman and CEO,Fidelity Advisor Sustainable Multi-Asset Fund